These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 33828297)

  • 1. Genome-wide enhancer maps link risk variants to disease genes.
    Nasser J; Bergman DT; Fulco CP; Guckelberger P; Doughty BR; Patwardhan TA; Jones TR; Nguyen TH; Ulirsch JC; Lekschas F; Mualim K; Natri HM; Weeks EM; Munson G; Kane M; Kang HY; Cui A; Ray JP; Eisenhaure TM; Collins RL; Dey K; Pfister H; Price AL; Epstein CB; Kundaje A; Xavier RJ; Daly MJ; Huang H; Finucane HK; Hacohen N; Lander ES; Engreitz JM
    Nature; 2021 May; 593(7858):238-243. PubMed ID: 33828297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INFERNO: inferring the molecular mechanisms of noncoding genetic variants.
    Amlie-Wolf A; Tang M; Mlynarski EE; Kuksa PP; Valladares O; Katanic Z; Tsuang D; Brown CD; Schellenberg GD; Wang LS
    Nucleic Acids Res; 2018 Sep; 46(17):8740-8753. PubMed ID: 30113658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative functional genomics framework for effective identification of novel regulatory variants in genome-phenome studies.
    Zhao J; Cheng F; Jia P; Cox N; Denny JC; Zhao Z
    Genome Med; 2018 Jan; 10(1):7. PubMed ID: 29378629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk.
    Ying P; Chen C; Lu Z; Chen S; Zhang M; Cai Y; Zhang F; Huang J; Fan L; Ning C; Li Y; Wang W; Geng H; Liu Y; Tian W; Yang Z; Liu J; Huang C; Yang X; Xu B; Li H; Zhu X; Li N; Li B; Wei Y; Zhu Y; Tian J; Miao X
    Nat Commun; 2023 Sep; 14(1):5958. PubMed ID: 37749132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits.
    Corradin O; Saiakhova A; Akhtar-Zaidi B; Myeroff L; Willis J; Cowper-Sal lari R; Lupien M; Markowitz S; Scacheri PC
    Genome Res; 2014 Jan; 24(1):1-13. PubMed ID: 24196873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of chromatin interactions at disease associated loci links novel candidate genes to inflammatory bowel disease.
    Meddens CA; Harakalova M; van den Dungen NA; Foroughi Asl H; Hijma HJ; Cuppen EP; Björkegren JL; Asselbergs FW; Nieuwenhuis EE; Mokry M
    Genome Biol; 2016 Nov; 17(1):247. PubMed ID: 27903283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.
    Mokry M; Middendorp S; Wiegerinck CL; Witte M; Teunissen H; Meddens CA; Cuppen E; Clevers H; Nieuwenhuis EE
    Gastroenterology; 2014 Apr; 146(4):1040-7. PubMed ID: 24333384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
    Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
    Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer Dysfunction in 3D Genome and Disease.
    Xia JH; Wei GH
    Cells; 2019 Oct; 8(10):. PubMed ID: 31635067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations.
    Fulco CP; Nasser J; Jones TR; Munson G; Bergman DT; Subramanian V; Grossman SR; Anyoha R; Doughty BR; Patwardhan TA; Nguyen TH; Kane M; Perez EM; Durand NC; Lareau CA; Stamenova EK; Aiden EL; Lander ES; Engreitz JM
    Nat Genet; 2019 Dec; 51(12):1664-1669. PubMed ID: 31784727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease.
    D'Aurizio R; Catona O; Pitasi M; Li YE; Ren B; Nicolis SK
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative enhancer sites in the bovine genome are enriched with variants affecting complex traits.
    Wang M; Hancock TP; MacLeod IM; Pryce JE; Cocks BG; Hayes BJ
    Genet Sel Evol; 2017 Jul; 49(1):56. PubMed ID: 28683716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of functional enhancer variants associated with type I diabetes in CD4+ T cells.
    Mishra A; Jajodia A; Weston E; Jayavelu ND; Garcia M; Hossack D; Hawkins RD
    Front Immunol; 2024; 15():1387253. PubMed ID: 38947339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
    Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R
    Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An encyclopedia of enhancer-gene regulatory interactions in the human genome.
    Gschwind AR; Mualim KS; Karbalayghareh A; Sheth MU; Dey KK; Jagoda E; Nurtdinov RN; Xi W; Tan AS; Jones H; Ma XR; Yao D; Nasser J; Avsec Ž; James BT; Shamim MS; Durand NC; Rao SSP; Mahajan R; Doughty BR; Andreeva K; Ulirsch JC; Fan K; Perez EM; Nguyen TC; Kelley DR; Finucane HK; Moore JE; Weng Z; Kellis M; Bassik MC; Price AL; Beer MA; Guigó R; Stamatoyannopoulos JA; Lieberman Aiden E; Greenleaf WJ; Leslie CS; Steinmetz LM; Kundaje A; Engreitz JM
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.
    Parker SC; Stitzel ML; Taylor DL; Orozco JM; Erdos MR; Akiyama JA; van Bueren KL; Chines PS; Narisu N; ; Black BL; Visel A; Pennacchio LA; Collins FS; ;
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17921-6. PubMed ID: 24127591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between enhancer variants and environmental factors as an overlooked aetiological paradigm in human complex disease.
    Robert S; Rada-Iglesias A
    Bioessays; 2023 Oct; 45(10):e2300038. PubMed ID: 37170707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Resolution Regulatory Maps Connect Vascular Risk Variants to Disease-Related Pathways.
    Åkerborg Ö; Spalinskas R; Pradhananga S; Anil A; Höjer P; Poujade FA; Folkersen L; Eriksson PP; Sahlén P
    Circ Genom Precis Med; 2019 Mar; 12(3):e002353. PubMed ID: 30786239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers.
    Cai YM; Lu ZQ; Li B; Huang JY; Zhang M; Chen C; Fan LY; Ma QY; He CY; Chen SN; Jiang Y; Li YM; Ning CB; Zhang FW; Wang WZ; Liu YZ; Zhang H; Jin M; Wang XY; Han JX; Xiong Z; Cai M; Huang CQ; Yang XJ; Zhu X; Zhu Y; Miao XP; Zhang SK; Wei YC; Tian JB
    Mil Med Res; 2024 Jun; 11(1):36. PubMed ID: 38863031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems Genetics in Human Endothelial Cells Identifies Non-coding Variants Modifying Enhancers, Expression, and Complex Disease Traits.
    Stolze LK; Conklin AC; Whalen MB; López Rodríguez M; Õunap K; Selvarajan I; Toropainen A; Örd T; Li J; Eshghi A; Solomon AE; Fang Y; Kaikkonen MU; Romanoski CE
    Am J Hum Genet; 2020 Jun; 106(6):748-763. PubMed ID: 32442411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.